Upload
Featured Recent Articles Topics Login Upload

Search Results for 'patients cvd'

patients cvd published presentations and documents on DocSlides.

Page 2 of 19al Cardiovasc Diabetol 2018 1783
Page 2 of 19al Cardiovasc Diabetol 2018 1783
by alis
Backgrounde International Diabetes Federation (ID...
VOL 61OCTOBEROCTOBRE 2015 Canadian Family PhysicianLe Mdecin de fam
VOL 61OCTOBEROCTOBRE 2015 Canadian Family PhysicianLe Mdecin de fam
by jovita
Simplied lipid guidelinesPrevention and manag...
Homozygous-recessive characteristics (HRCs) and biochemical parameters as biomarkers of cardiovas
Homozygous-recessive characteristics (HRCs) and biochemical parameters as biomarkers of cardiovas
by RockOn
Darko Grujičić. 1*. , . Ljiljana Mirkov . 2. , ...
Jehonathan Pinthus , MD, PhD
Jehonathan Pinthus , MD, PhD
by lucinda
McMaster University. Hamilton, ON, Canada. ADT Imp...
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthri
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthri
by celsa-spraggs
Slide 1: . Target. population/question. 2. 09/01...
DECLARE – TIMI 58 Stephen D. Wiviott, MD
DECLARE – TIMI 58 Stephen D. Wiviott, MD
by debby-jeon
for the DECLARE – TIMI 58 Investigators. Americ...
CVD Fellowship QI Project Ideas – Further Information
CVD Fellowship QI Project Ideas – Further Information
by brooke
01. Project Ideas. 2. QI Project Ideas. 3. Familia...
Cardiovascular Disease in HIV
Cardiovascular Disease in HIV
by stella
Steven K. Grinspoon, MD. Professor of Medicine. Ha...
Evolving Role of the CV Clinician in Managing CV Risk in Type 2 Diabetes: Rationale and Opportuniti
Evolving Role of the CV Clinician in Managing CV Risk in Type 2 Diabetes: Rationale and Opportuniti
by vivian
Nathan D. Wong, PhD, FACC, FAHA, FNLA, FASPC. Prof...
Understanding Risk Factors of Cardiovascular Disease and Management Guidance for Men on Androgen De
Understanding Risk Factors of Cardiovascular Disease and Management Guidance for Men on Androgen De
by jacey
Prostate Cancer . US Medical Affairs, Research . a...
Non-obese rheumatoid arthritis patients
Non-obese rheumatoid arthritis patients
by valerie
withlow. low-density lipoprotein have higher coro...
Familial Hypercholesterolemia
Familial Hypercholesterolemia
by faustina-dinatale
KEY POINTS . FH is an autosomal dominant genetic...
E. David Crawford, MD University of Colorado, Denver
E. David Crawford, MD University of Colorado, Denver
by faustina-dinatale
Aurora, CO. Introduction and Current ADT Challeng...
Prevention of MACROvascular
Prevention of MACROvascular
by queenie
Complications of Diabetes. Matt Bouchonville, MD, ...
1/19/2018 1 1/19/2018 2 Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabet
1/19/2018 1 1/19/2018 2 Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabet
by ida
Farzad. . Hadaegh. , MD, . Professor of Internal ...
Cardiovascular Clinical Programme
Cardiovascular Clinical Programme
by cady
Programme Team. Zoe Hamilton –Clinical Programme...
A Clinical Approach Utilizing GLP-1 RAs
A Clinical Approach Utilizing GLP-1 RAs
by udeline
Diabetes Management . for the Cardiologist. Confid...
Rehabilitating elderly cardiac patients
Rehabilitating elderly cardiac patients
by ellena-manuel
By Tiffany Steele, SPTA. Objectives:. 1. Cardiova...
Circulating Progenitor Cells and Cardiovascular Disease
Circulating Progenitor Cells and Cardiovascular Disease
by jane-oiler
Arshed A. Quyyumi, MD . Professor of Medicine . E...
Women and Heart Disease
Women and Heart Disease
by cheryl-pisano
Directed Readings . In the Classroom. September/O...
Prevention of cardiovascular risk in diabetes
Prevention of cardiovascular risk in diabetes
by danika-pritchard
Applying evidence based medicine to clinical care...
Women and Heart Disease Directed Readings
Women and Heart Disease Directed Readings
by alexa-scheidler
In the Classroom. September/October 2013 issue of...
DYSLIPIDEMIA IN DIABETES
DYSLIPIDEMIA IN DIABETES
by esther
MAHTAB NIROOMAND M.D.. Assistant professor of End...
Session 2 Lecture 2 What Defines a Healthy GIT Microbiome in the USA?
Session 2 Lecture 2 What Defines a Healthy GIT Microbiome in the USA?
by eddey
Healthy:. . . A population of 10. 14. bacteria...
Cardiovascular Disease Risk Tests
Cardiovascular Disease Risk Tests
by jordyn
Page 1 of 20 UnitedHealthcare Commercial Medical...
Management of Dyslipidaemia
Management of Dyslipidaemia
by anderson
July 2017 Edition of Clinical Practice Guidelines ...
CLINICAL PRACTICE
CLINICAL PRACTICE
by mia
USTRALIAN FAMILY Vol. 37, No. 7, July 2008 ichard ...
Topic 1 Cardiovascular diseases
Topic 1 Cardiovascular diseases
by okelly
- Improved prediction, prevention, diagnosis and ...
Homocysteine enzymatic assayA strong independent risk factor for card
Homocysteine enzymatic assayA strong independent risk factor for card
by anya
modular platform, the 8000 modular analyzer serie...
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: Ind
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: Ind
by paige
Slide deck. The full text of the paper is availabl...
Sglt2 inhibitor Dr. NOUSHIN-KHALILI
Sglt2 inhibitor Dr. NOUSHIN-KHALILI
by roxanne
ENDOCRINOLOGIST. 97.12.7. Diabetes Prevalence in I...
A cluster randomised controlled trial
A cluster randomised controlled trial
by eliza
testing an intervention . to. lower cardiovascula...
The Research Question One in two individuals prescribed statins for primary prevention of cardiovas
The Research Question One in two individuals prescribed statins for primary prevention of cardiovas
by morgan
The research aimed to derive and externally valida...